Researchers show multi-cancer early detection potential of glycosaminoglycans as biomarkers
Swedish cancer detection company Elypta has published groundbreaking research showcasing the multi-cancer early detection (MCED) potential of glycosaminoglycans as biomarkers of tumour metabolism. The research conducted at Chalmers University of Technology by Elypta founders Prof. Jens Nielsen and Dr Francesco Gatto has been published in Proceedings of the National Academy of Sciences (PNAS). doi: https://doi.org/10.1073/pnas.2115328119
